Related Experiment Video
Updated: Jul 16, 2026
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Suicide genes for cancer therapy
Daniel Portsmouth1, Juraj Hlavaty, Matthias Renner
1Research Institute for Virology and Biomedicine, University of Veterinary Medicine, Vienna, Austria.
Abstract:
The principle of using suicide genes for gene directed enzyme prodrug therapy (GDEPT) of cancer has gained increasing significance during the 20 years since its inception. The astute application of suitable GDEPT systems should permit tumour ablation in the absence of off-target toxicity commonly associated with classical chemotherapy, a hypothesis which is supported by encouraging results in a multitude of pre-clinical animal models. This review provides a clear explanation of the rationale behind the GDEPT principle, outlining the advantages and limitations of different GDEPT strategies with respect to the roles of the bystander effect, the immune system and the selectivity of the activated prodrug in contributing to their therapeutic efficacy. An in-depth analysis of the most widely used suicide gene/prodrug combinations is presented, including details of the latest advances in enzyme and prodrug optimisation and results from the most recent clinical trials.
Insights
Gene Directed Enzyme Prodrug Therapy (GDEPT) offers a promising cancer treatment strategy. This review explores GDEPT systems, their efficacy, and limitations for improved tumor ablation with reduced toxicity.
Area of Science:
- Oncology
- Gene Therapy
- Pharmacology
Background:
- Gene Directed Enzyme Prodrug Therapy (GDEPT) has evolved significantly over 20 years.
- GDEPT aims for tumor ablation with reduced off-target toxicity compared to traditional chemotherapy.
- Pre-clinical models show encouraging results for GDEPT's therapeutic potential.
Purpose of the Study:
- To explain the rationale behind the GDEPT principle.
- To outline advantages and limitations of various GDEPT strategies.
- To analyze suicide gene/prodrug combinations and recent clinical trial outcomes.
Main Methods:
- Review of existing literature on GDEPT systems.
- Analysis of the roles of bystander effect, immune system, and prodrug selectivity.
- In-depth examination of suicide gene/prodrug combinations.
- Assessment of recent advancements in enzyme and prodrug optimization.
Main Results:
- GDEPT systems demonstrate potential for targeted tumor destruction.
- Factors like bystander effect, immune response, and prodrug selectivity influence efficacy.
- Optimized enzyme-prodrug systems and recent clinical trials show progress.
Conclusions:
- GDEPT represents a significant advancement in cancer therapy.
- Understanding GDEPT components is crucial for maximizing therapeutic benefits.
- Ongoing research focuses on optimizing GDEPT for enhanced clinical outcomes.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...